An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
Sign Up to like & getrecommendations! Published in 2021 at "Oncoimmunology"
DOI: 10.1080/2162402x.2021.1947665
Abstract: ABSTRACT Pulmonary sarcomatoid carcinoma (PSC) is an uncommon subtype of lung cancer, and immune checkpoint blockade promises in clinical benefit. However, virtually nothing is known about the expression of common immune checkpoints in PSC. Here,… read more here.
Keywords: sarcomatoid carcinoma; risk; psc; pulmonary sarcomatoid ... See more keywords